Identification of Risk Factors for Abnormal Postoperative Chemistry Labs after Primary Shoulder Arthroplasty | ||
| The Archives of Bone and Joint Surgery | ||
| مقاله 6، دوره 6، شماره 4، مهر 2018، صفحه 282-288 اصل مقاله (361.54 K) | ||
| نوع مقاله: RESEARCH PAPER | ||
| شناسه دیجیتال (DOI): 10.22038/abjs.2018.26686.1706 | ||
| نویسندگان | ||
| Alexis A. Williams1؛ Eric H. Tischler2؛ Daniel Sholder2؛ Thema A. Nicholson2؛ Mitchell G. Maltenfort2؛ Charles Getz2؛ Gerald Williams Jr2؛ Surena Namdari* 2 | ||
| 1Sidney Kimmel Medical College at Thomas Jefferson University, Department of Orthopaedics Surgery, Philadelphia, PA | ||
| 2The Rothman Institute, Thomas Jefferson University, 925 Chestnut St. 5th Floor, Philadelphia, PA | ||
| چکیده | ||
| Purpose Purpose The purpose of this study was to determine patient-specific risk factors and clinical intervention rates for abnormal postoperative Chem-7 panels in shoulder arthroplasty patients. Methods Retrospectively, all primary anatomic total (aTSA) and reverse shoulder (RTSA) arthroplasties (between 2007-2013) performed at a single institution were identified. All patients underwent routine preoperative and postoperative day one (POD1) chemistry panels. Each clinically significant component of the Chem-7 panel was independently evaluated using a multivariate analysis to identify risk factors for abnormal results. Associated clinical intervention rates were also calculated. Results Data from 1,012 patients (248 RTSA; 764 aTSA) was analyzed. 5.4% of patients had at least one preoperative abnormal chemistry result. On multivariate analysis, patients with abnormal preoperative Chem-7 labs and a history of renal disease had significantly increased risk for abnormal POD1 labs (p <0.001). Although 25.6% (259/1,012) of patients had at least one abnormal POD1 lab result, the total postoperative clinical intervention rate was 15.1% (39/259). Conclusion Renal disease and a preoperative abnormal chemistry result are important risk factors for abnormal postoperative Chem-7. Optimizing renal status and correcting abnormal blood chemistry results preoperatively may reduce the incidence of abnormal postoperative chemistry results. | ||
| کلیدواژهها | ||
| Blood chemistry؛ Laboratory order؛ Reverse shoulder arthroplasty؛ Risk stratification؛ Total Shoulder Arthroplasty | ||
| مراجع | ||
|
1. Kraft MD, Btaiche IF, Sacks GS, Kudsk KA. Treatment of electrolyte disorders in adult patients in the intensive care unit. Am J Health Syst Pharm. 2005; 62(16):1663-82. 2. Tambe AA, Hill R, Livesley PJ. Post-operative hyponatraemia in orthopaedic injury. Injury. 2003; 34(4):253-5. 3. Anthony CA, Westermann RW, Gao Y, Pugely AJ, Wolf BR, Hettrich CM. What are risk factors for 30- day morbidity and transfusion in total shoulder arthroplasty? A review of 1922 cases. Clin Orthop Relat Res. 2015; 473(6):2099-105. 4. Jiang JJ, Toor AS, Shi LL, Koh JL. Analysis of perioperative complications in patients after total shoulder arthroplasty and reverse total shoulder arthroplasty. J Shoulder Elbow Surg. 2014; 23(12):1852-9. 5. Waterman BR, Dunn JC, Bader J, Urrea L, Schoenfeld AJ, Belmont PJ Jr. Thirty-day morbidity and mortality after elective total shoulder arthroplasty: patientbased and surgical risk factors. J Shoulder Elbow Surg. 2015; 24(1):24-30. 6. Day JS, Lau E, Ong KL, Williams GR, Ramsey ML, Kurtz SM. Prevalence and projections of total shoulder and elbow arthroplasty in the United States to 2015. J Shoulder Elbow Surg. 2010; 19(8):1115-20. 7. Freeborn DK, Baer D, Greenlick MR, Bailey JW. Determinants of medical care utilization: physicians’ use of laboratory services. Am J Public Health. 1972; 62(6):846-53. 8. Schleicher E. The clinical chemistry laboratory: current status, problems and diagnostic prospects. Anal Bioanal Chem. 2006; 384(1):124-31. 9. Kreines A, McMillan S, Ford E, Dingle A. Reverse total shoulder arthroplasty for the treatment of synovial chondromatosis: a case report and review of the literature. Arch Bone Jt Surg. 2017; 5(2):117-20. 10. Epstein M. Aging and the kidney. J Am Soc Nephrol. 1996; 7(8):1106-22. 11. Murphy AM, Tunitsky-Bitton E, Krlin RM, Barber MD, Goldman HB. Utility of postoperative laboratory studies after female pelvic reconstructive surgery. Am J Obstet Gynecol. 2013; 209(4):363.e1-5. 12. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem. 1992; 38(10):1933-53. 13. Kamath AF, McAuliffe CL, Kosseim LM, Pio F, Hume E. Malnutrition in joint arthroplasty: prospective study indicates risk of unplanned ICU admission. Arch Bone Jt Surg. 2016; 4(2):128-31. 14. Feinfeld DA, Bargouthi H, Niaz Q, Carvounis CP. Massive and disproportionate elevation of blood urea nitrogen in acute azotemia. Int Urol Nephrol. 2002; 34(1):143-5. 15. Stark JL. BUN/creatinine: your keys to kidney function. Nursing. 1980; 10(5):33-8. 16. Stookey JD, Pieper CF, Cohen HJ. Is the prevalence of dehydration among community-dwelling older adults really low? Informing current debate over the fluid recommendation for adults aged 70+years. Public Health Nutr. 2005; 8(8):1275-85. 17. Robinson BE, Weber H. Dehydration despite drinking: beyond the BUN/Creatinine ratio. J Am Med Dir Assoc. 2004; 5(2 Suppl):S67-71. 18. Thomas DR, Tariq SH, Makhdomm S, Haddad R, Moinuddin A. Physician misdiagnosis of dehydration in older adults. J Am Med Dir Assoc. 2004; 5(2 Suppl):S30-4. | ||
|
آمار تعداد مشاهده مقاله: 882 تعداد دریافت فایل اصل مقاله: 390 |
||